Incompatibilità Rh: dopo l'anti-D, la nuova sfida è fermare gli anticorpi
Medico e Bambino Pagine elettroniche · 16.11.2026 · 29 (9) · 265-267
DOI: 10.53126/mebxxixn265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medico e Bambino Pagine elettroniche, online erschienen am 16.11.2026. Verfasst von Mario De Curtis. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Haemolytic disease of the foetus and newborn (HDFN), caused by maternal alloimmunization against fetal red blood cell antigens, has been significantly reduced in its RhD-related form by anti-D immunoglobulin prophylaxis in RhD-negative women. However, it remains a serious concern in pregnancies of already alloimmunized women. Non-invasive monitoring of foetal anaemia relies on Doppler ultrasonography to measure the middle cerebral artery peak systolic velocity (MCA-PSV), while intrauter-ine transfusion (IUT) remains the standard treatment for severe fetal anaemia. To prevent the development of anaemia, research is exploring novel therapeutic strate-gies such as nipocalimab, a monoclonal antibody that blocks the neonatal Fc receptor (FcRn), thereby reducing the placental transfer of maternal IgG antibodies. Pre-liminary results from the phase 2 UNITY trial are prom-ising and suggest the potential to reduce the need for in-trauterine transfusions. The ongoing phase 3 AZALEA trial and further safety assessments will help clarify the efficacy and safety of this approach.
Zitieren
APA
Curtis, M. D. (2026). Incompatibilità Rh: dopo l'anti-D, la nuova sfida è fermare gli anticorpi. Medico e Bambino Pagine elettroniche, 29(9), 265-267. https://doi.org/10.53126/mebxxixn265
Vancouver
Curtis MD. Incompatibilità Rh: dopo l'anti-D, la nuova sfida è fermare gli anticorpi. Medico e Bambino Pagine elettroniche. 2026;29(9):265-267. doi:10.53126/mebxxixn265
BibTeX
@article{Curtis2026,
author = {Curtis, Mario De},
title = {Incompatibilità Rh: dopo l'anti-D, la nuova sfida è fermare gli anticorpi},
journal = {Medico e Bambino Pagine elettroniche},
year = {2026},
volume = {29},
number = {9},
pages = {265--267},
doi = {10.53126/mebxxixn265}
}
EUVIMED